[1] STORCH E K,CUSTER B S,JACOBS M R,et al.Review of current transfusion therapy and blood banking practices[J]. Blood Rev,2019,38:100593. [2] 中国输血协会. 血液安全监测指南[S]. 2015. [3] BASSI R,AGGARWAL S,BHARDWAJ K,et al.Patterns of adverse transfusion reactions in a tertiary care centre of north India:a step towards hemovigilance[J]. Indian J Hematol Blood Transfus,2017,33(2):248-253. [4] GUO K,WANG X H,ZHANG H M,et al.Transfusion reactions in pediatric patients:an analysis of 5 years of hemovigilance data from a national center for children's health in China[J]. Front Pediatr,2021,9:660297. [5] KRACALIK I,MOWLA S,BASAVARAJU S V,et al.Transfusion-related adverse reactions:data from the national healthcare safety network hemovigilance module - United States,2013-2018[J]. Transfusion,2021,61(5):1424-1434. [6] HARVEY A R,BASAVARAJU S V,CHUNG K W,et al.Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module,United States,2010 to 2012[J]. Transfusion,2015,55(4):709-718. [7] 夏紫怡,宋敏,王珊,等. 173例输血不良反应相关影响因素分析[J].国际检验医学杂志,2021,42(15):1866-1869. [8] BASSI R,AGGARWAL S,BHARDWAJ K,et al.Patterns of adverse transfusion reactions in a tertiary care centre of north India:a step towards hemovigilance[J]. Indian J Hematol Blood Transfus,2017,33(2):248-253. [9] 滕方,张燕,孙桂香,等. 我国三甲医院输血不良反应发生率的Meta分析[J]. 中国循证医学杂志,2015,15(3):282-289. [10] CHO J,CHOI S J,KIM S,et al.Frequency and pattern of noninfectious adverse transfusion reactions at a tertiary care hospital in Korea[J]. Ann Lab Med,2016,36(1):36-41. [11] 王向明,柏灵灵,王珏,等.一家三甲医院近7年输血不良反应的发生情况及原因分析[J].中国输血杂志,2017,30(4):375-378. [12] KATO H,NAKAYAMA T,URUMA M,et al.Repeated exposure rather than the total volume of transfused components may influence the incidence of allergic transfusion reactions[J]. Transfusion,2015,55(11):2576-2581. [13] GOLDFINGER D,LOWE C.Prevention of adverse reactions to blood transfusion by the administration of saline-washed red blood cells[J]. Transfusion,1981,21(3):277-280. [14] DELANEY M,WENDEL S,BERCOVITZ R S,et al.Transfusion reactions:prevention,diagnosis,and treatment[J]. Lancet,2016,388(10061):2825-2836. [15] KING K E,SHIREY R S,THOMAN S K,et al.Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs[J]. Transfusion,2004,44(1):25-29. [16] BILGIN Y M,VAN DE WATERING L M G,BRAND A. Clinical effects of leucoreduction of blood transfusions[J]. Neth J Med,2011,69(10):441-450. [17] POLITIS C,KAVALLIEROU L,HANTZIARA S,et al.Haemovigilance data on the use of methylene blue virally inactivated fresh frozen plasma with the Theraflex MB-Plasma System in comparison to quarantine plasma:11 years' experience[J]. Transfus Med,2014,24(5):316-320. [18] 刘晓洋,李小阳. 去冷沉淀血浆和普通冰冻血浆的质量对比分析[J]. 临床输血与检验,2012,14(2):158-160. [19] 徐彪,夏冬梅,邵淑芳. 手工法和机采法制备浓缩血小板临床应用产生的不良反应比较[J]. 河南肿瘤学杂志,2001,14(5):361. [20] VOSSOUGHI S,PEREZ G,WHITAKER B I,et al.Analysis of pediatric adverse reactions to transfusions[J]. Transfusion,2018,58(1):60-69. [21] 甘珊,王佳,徐春芬,等. 130例儿童输血不良反应回顾性分析[J]. 中国输血杂志,2018,31(8):865-867. [22] SOSTIN N,HENDRICKSON J E.Pediatric hemovigilance and adverse transfusion reactions[J]. Clin Lab Med,2021,41(1):51-67. [23] 王雨涵,江灵,王洁,等. 血液病输血不良反应特征分析及处理措施[J]. 西南医科大学学报,2020,43(2):173-177. [24] 罗利,蒋开明. 5W+1H分析法结合ECRS分析原则在降低输血不良反应漏报率中的应用[J].中国输血杂志,2021,34(8):870-873. [25] 苏莉,王红波,杨家焕,等.477例临床输血不良反应调查及分析[J]. 中国输血杂志,2019,32(10):1027-1031. [26] 路国强,何有云,申红英,等. 12406例输血患者临床输血不良反应调查分析[J].中国卫生检验杂志,2014,24(22):3313-3314. [27] YIN Y H,TIAN X,LI L,et al.First annual report of Chinese haemovigilance network[J].Vox Sang,2021,116(6):718-724. |